Tomer Faraggi

Tomer Faraggi serves as a Senior Scientist at Parabilis Medicines, focusing on the development of scalable routes to active pharmaceutical ingredients and optimizing synthetic pathways for stapled peptides since January 2022. Previously, Tomer worked as a Technical Expert 2 at Syngenta, synthesizing carbon-14 labeled compounds for metabolic studies from November 2019 to December 2021. Earlier experience includes a role as a Graduate Research Assistant at Princeton University under Professor David W. C from August 2014 to October 2019, and as a Research Scientist at Evotec, where involvement centered on drug discovery for oncology-relevant protein-protein interactions from August 2013 to January 2014. Tomer holds a PhD in Organic Chemistry from Princeton University and an MChem in Chemistry from the University of Oxford.